However, the Cxcl1 level, another pro-inflammatory chemokine, was drastically increased (~30–60-fold) in the same LLC-derived tumor samples, which is the opposite to the suppressed features (~7–8-fold) shown in TRAMP-C1 derived tumor tissues (Figure 3C). The gene discussed is CXCL1; the disease is neoplasm.